Concepedia

Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

Qian Chen, Celia Perales, María Eugenia Soria, Damir García‐Cehic, Josep Gregori, Francisco Rodríguez‐Frias, Javier Crespo, José Luís Calleja, David Tabernero, Marta Vila,

Antiviral Research · 2019 · 47 citations · 27 references

DOIFull text

Open access

Concepts

References

27

EASL Recommendations on Treatment of Hepatitis C 2018

Jean–Michel Pawlotsky, Francesco Negro, Alessio Aghemo et al. · Journal of Hepatology · 2018 · 2.8K citations

, , +14

Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials

Evguenia S. Svarovskaia, Hadas Dvory‐Sobol, Neil Parkin et al. · Clinical Infectious Diseases · 2014 · 216 citations · Full text

, , +17

Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir

Christoph Sarrazin, Hadas Dvory‐Sobol, Evguenia S. Svarovskaia et al. · Gastroenterology · 2016 · 211 citations · Full text

, , +14

NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome

Stefan Zeuzem, Masashi Mizokami, Stephen Pianko et al. · Journal of Hepatology · 2017 · 203 citations · Full text

, , +17

Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir

Eric Donaldson, Patrick R. Harrington, Julian J. O’Rear et al. · Hepatology · 2014 · 173 citations

, , +17